An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect
Por um escritor misterioso
Descrição
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology
Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study - ScienceDirect
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study - ScienceDirect
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis - European Urology Focus
Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study - eBioMedicine
A modified nutrition risk screening 2002 predicts the risk of death among hospitalized patients with COVID-19 - Clinical Nutrition ESPEN
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM - eBioMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
